DocuSign shareholder plans Rule 144 stock sale

A shareholder of DocuSign has filed a notice of proposed sale under Rule 144 to sell 26,250 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate sale date of 01/09/2026.

Rhea-AI Filing Summary

A shareholder of DocuSign has filed a notice of proposed sale under Rule 144 to sell 26,250 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate sale date of 01/09/2026. The filing lists an aggregate market value of $1,832,250.00 for these shares, compared with 200,272,740 shares outstanding of the same class.

The shares to be sold were acquired as restricted stock units from the issuer on 10/10/2024, in a non-cash transaction noted as “N/A” for the nature of payment. The filer represents that they are not aware of undisclosed material adverse information about DocuSign’s current or prospective operations, as required for a Rule 144 sale.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the DocuSign (DOCU) Rule 144 filing disclose?

The filing discloses that a DocuSign shareholder intends to sell 26,250 shares of common stock under Rule 144 through Morgan Stanley Smith Barney LLC on the NASDAQ around 01/09/2026.

How many DocuSign (DOCU) shares are covered by this planned sale?

The notice covers a proposed sale of 26,250 shares of DocuSign common stock with an aggregate market value of $1,832,250.00.

How were the DocuSign (DOCU) shares in this Rule 144 filing acquired?

The shares were acquired as restricted stock units from the issuer on 10/10/2024, with the nature of payment indicated as N/A.

How many DocuSign (DOCU) shares of this class are outstanding?

The filing reports that 200,272,740 shares of the same class of DocuSign common stock were outstanding at the time referenced.

Which broker will handle the planned DocuSign (DOCU) share sale?

The shares are listed to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, NY 10004.

What representation does the selling DocuSign (DOCU) shareholder make in this notice?

By signing, the shareholder represents that they do not know any material adverse information about DocuSign’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/09/2026 - 04:31 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001657309
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	DOCUSIGN INC
SEC File Number	001-38465
Address of Issuer	221 Main St, Suite 800 San Francisco CALIFORNIA 94105
Phone	4154894940
Name of Person for Whose Account the Securities are To Be Sold	ALLAN THYGESEN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	26250	1832250.00	200272740	01/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/10/2024	Restricted Stock Units	Issuer			26250	10/10/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 10/10/2024 through 04/10/2025.
Date of Notice	01/09/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	10/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Allan Thygesen
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)